rfhg_181063.1

Basic information about the TSS

---

TSS ID: rfhg_181063.1 Species: human Chr: chr16		Start: 11839847 End: 11839942 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS,CTCF-bound (EH38D0688923,EH38E0394184)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK025446:43 GeneID: 26156 HGNC/MGI_ID: HGNC:24534 UniProt_ID: Nearer transcript ids and distances:

Gene_name: ribosomal L1 domain containing 1 Gene_symbol: RSL1D1 Gene_synonyms: CSIG DKFZP564M182 L12 PBK1 UTP30 Gene_source: HGNC:24534

TATA-Box annotation

---

Distance to TSS:	-11062
Nearest PromoterID:	NR_131216
Entrez ID:	400500
Nearest Unigene:	Hs.24611
Nearest Refseq:	NR_024049
Nearest Ensembl:	ENSG00000262117
Gene Name:	ribosomal L1 domain containing 1
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	0.458333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RSL1D1 p2@RSL1D1 p3@RSL1D1 p4@RSL1D1 p5@RSL1D1
Sample		p1@RSL1D1	p2@RSL1D1	p3@RSL1D1	p4@RSL1D1	p5@RSL1D1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	141.62	9.55	12.27	6.43	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	147.49	8.90	12.54	5.26	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	169.76	9.65	14.66	7.52	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	146.16	9.15	10.40	2.91	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	158.15	5.85	12.15	3.37	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	168.03	8.14	13.76	3.10	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	220.93	14.60	28.32	7.19	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	160.59	7.75	24.95	3.63	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	166.91	7.05	20.73	2.78	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	181.42	5.22	22.61	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	173.82	4.45	19.00	5.26	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	186.61	2.85	15.86	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	69.31	2.42	1.29	0.64	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	79.69	3.16	0.75	1.50	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	63.89	2.85	1.54	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	63.88	1.26	2.51	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	72.07	1.53	1.97	0.87	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	56.52	2.11	2.53	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	69.84	3.20	1.60	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	61.83	1.35	1.65	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	67.76	2.41	2.00	0.53	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	85.10	1.90	2.59	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	71.48	2.20	1.94	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	71.59	2.67	2.43	0.24	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	69.40	1.55	0.52	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	56.97	4.11	1.90	1.27	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	71.98	4.95	1.10	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	90.06	3.77	1.89	1.18	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	64.45	1.94	1.13	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	71.12	2.17	2.90	0.90	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	64.90	1.47	0.84	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	65.26	1.17	1.76	0.59	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	67.95	2.11	1.90	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	107.21	1.65	2.47	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	62.45	2.43	0.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	72.63	1.72	2.11	0.77	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	62.13	1.84	1.02	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	67.70	1.61	1.61	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	59.15	3.24	1.62	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	69.14	0.72	1.92	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	68.70	1.88	0.47	0.71	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	86.96	0.73	2.64	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	55.47	0.84	1.27	1.27	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	56.47	1.40	1.05	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	51.00	2.01	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	53.97	3.02	1.40	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	46.78	0.72	1.44	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	47.09	0.89	0.89	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	37.10	0.48	1.20	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	53.99	1.42	1.62	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	46.73	1.02	1.02	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	43.81	3.56	1.11	0.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1049.41	55.97	13.99	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	33.36	1.42	0.35	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	42.75	0.66	0.99	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	268.46	21.81	0.84	5.03	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	75.77	4.59	2.30	1.38	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	37.92	2.27	0.97	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	35.97	1.93	0.64	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	80.15	1.89	1.26	0.94	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	47.94	2.12	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	36.45	3.93	0.00	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	101.91	17.52	3.18	3.98	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	48.59	1.70	1.02	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	32.49	0.65	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	28.04	2.13	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	905.18	80.82	16.16	32.33	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	773.95	102.67	0.00	15.79	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	39.49	1.95	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	32.73	1.49	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	25.33	0.00	1.41	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	30.47	1.99	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	35.26	1.24	0.62	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.05	0.92	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	68.58	1.27	2.38	0.95	0.16
Adipocyte - breast, donor2	11327-117E4	60.32	2.09	3.53	1.12	0.48
Adipocyte - omental, donor1	11473-119C6	77.99	0.64	5.34	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	29.15	1.49	2.99	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	45.88	0.33	1.67	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	31.26	0.00	2.55	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	36.28	1.10	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	127.36	2.26	6.32	1.35	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	84.28	0.87	7.12	1.91	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	84.68	0.20	3.52	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	47.36	1.03	2.32	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	61.05	0.00	2.51	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	71.13	0.00	2.94	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	128.69	0.48	4.34	0.56	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	63.91	1.61	2.58	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	66.65	0.53	2.67	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	63.99	0.56	3.34	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	44.92	0.42	4.16	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	64.05	0.50	1.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	66.76	0.98	2.62	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	48.41	0.00	2.44	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	50.17	0.00	5.08	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	6.10	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	28.07	0.00	1.98	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	15.61	0.21	0.82	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	102.64	0.46	5.03	0.23	0.23
Anulus Pulposus Cell, donor2	11463-119B5	43.35	0.49	3.92	1.22	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	66.94	0.45	2.70	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	57.31	0.87	3.47	3.91	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	6.42	0.00	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	74.13	0.30	1.49	3.29	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	75.88	0.00	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	36.96	1.98	0.66	1.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	52.63	0.00	1.95	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	59.71	0.49	3.88	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	38.60	0.59	3.56	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	62.15	0.75	1.88	2.26	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	48.62	0.00	1.45	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	31.34	0.00	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	78.74	0.49	5.27	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	58.69	1.36	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	44.03	0.60	1.96	0.30	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	64.29	1.61	1.07	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	51.01	0.19	3.02	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	53.19	0.53	2.14	3.47	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	40.97	1.95	3.90	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	61.37	0.50	2.49	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	37.22	0.00	3.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	35.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	55.92	1.03	1.89	1.72	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	67.96	0.49	2.43	1.94	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	66.40	0.38	1.52	2.66	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	36.34	3.63	4.85	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	61.56	0.57	1.71	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	46.82	0.21	3.21	1.07	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	35.36	0.26	1.55	1.29	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	53.02	0.47	0.47	1.41	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	53.70	0.32	2.57	3.54	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	37.10	0.00	1.43	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	57.91	1.17	2.34	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	49.07	0.90	4.52	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	43.96	1.19	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	78.32	1.02	5.09	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	74.11	0.76	3.06	2.55	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	44.48	0.64	1.91	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	55.67	0.43	1.73	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	62.45	0.21	1.91	1.06	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	38.28	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	61.41	0.94	1.89	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	54.59	0.00	3.73	0.68	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	44.01	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	52.81	0.00	4.23	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	52.32	0.86	2.79	0.64	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	42.72	0.60	5.41	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	54.67	0.00	2.19	2.19	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	58.39	1.15	2.07	2.07	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	7.65	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	46.02	0.00	2.54	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	59.25	0.41	3.51	0.83	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	40.09	0.61	1.53	1.84	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	76.00	0.96	4.30	2.39	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	51.22	1.11	2.00	1.55	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	33.57	1.53	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	55.39	0.55	2.22	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	47.93	0.26	2.65	1.06	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	37.07	0.73	3.63	1.09	0.36
Astrocyte - cerebellum, donor1	11500-119F6	30.70	0.12	2.46	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	16.77	0.00	2.23	0.51	0.00
Astrocyte - cerebellum, donor3	11661-122F5	13.63	0.00	0.63	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	93.42	0.70	9.76	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	71.02	0.65	5.66	1.62	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	68.91	1.04	4.03	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	306.67	2.87	20.30	4.13	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	322.73	4.38	27.44	3.26	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	299.63	2.50	26.06	1.59	1.25
Basophils, donor1	12241-129G9	78.98	0.00	0.78	0.00	0.00
Basophils, donor2	12242-129H1	186.53	0.72	2.53	0.36	0.00
Basophils, donor3	12243-129H2	128.77	0.15	1.32	0.44	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	32.34	0.22	1.29	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.29	0.00	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	107.60	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	55.86	1.26	2.51	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	24.54	0.21	3.74	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	43.99	0.23	4.61	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	95.37	3.78	5.40	3.24	1.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	301.54	1.34	18.76	1.34	1.55
Burkitt's lymphoma cell line:RAJI	10476-106I8	291.13	1.63	19.33	2.10	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	304.11	0.32	3.52	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	310.26	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	130.18	0.56	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	84.45	2.23	1.30	1.48	0.56
CD14+ Monocytes, donor3	11381-118B4	69.59	1.54	1.10	2.41	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	114.07	0.28	1.42	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	130.40	0.00	2.65	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	148.59	0.33	2.30	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	71.12	0.29	0.00	0.72	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	75.44	0.60	0.91	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	63.72	1.18	0.00	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	45.20	0.17	0.33	0.67	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	51.89	2.76	0.55	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	67.93	0.99	0.25	0.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	37.59	0.78	0.00	0.39	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	58.40	1.60	0.53	0.53	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	87.27	0.44	0.22	0.65	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	52.44	0.47	0.23	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	104.02	2.11	1.06	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	59.91	0.00	2.22	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	58.16	0.89	0.74	0.89	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	68.25	1.80	1.20	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	90.98	1.25	0.83	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	51.48	0.69	0.00	1.14	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	81.21	0.90	0.45	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	52.38	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	36.85	0.54	0.27	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	80.25	2.62	0.17	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	57.23	1.68	0.84	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	46.66	0.73	0.37	1.10	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	48.26	1.76	0.70	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	49.58	1.32	0.00	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	40.11	1.05	0.17	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	64.30	5.20	1.49	1.12	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	104.76	0.86	0.65	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	43.41	0.00	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	74.18	1.62	1.16	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	77.95	0.93	0.46	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	143.64	1.09	2.18	1.09	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	136.98	1.15	1.39	1.62	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	120.01	0.65	1.73	1.30	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	202.13	0.78	3.58	1.40	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	158.05	0.52	3.49	1.22	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	226.98	1.78	3.12	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	103.86	0.26	1.02	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	102.10	0.44	1.32	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	121.48	0.21	1.89	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	128.04	0.00	8.13	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	150.51	0.00	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	113.92	1.04	3.11	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	179.63	0.53	2.67	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	198.88	1.07	3.22	1.61	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	144.60	0.70	5.62	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	134.12	0.00	2.35	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	143.69	0.00	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	99.45	2.47	0.82	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	136.38	3.63	6.53	2.90	1.45
CD19+ B Cells, donor3	11705-123B4	159.02	1.01	2.52	2.02	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	132.13	2.02	7.27	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	91.88	0.80	2.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	140.57	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	160.12	1.12	1.69	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	246.12	1.13	6.76	0.75	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	276.67	0.45	5.41	0.45	0.00
CD4+ T Cells, donor1	11225-116C1	301.36	1.07	5.00	1.43	0.71
CD4+ T Cells, donor2	11306-117C1	131.66	1.84	1.84	4.90	1.84
CD4+ T Cells, donor3	11382-118B5	152.80	4.88	0.91	5.18	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	202.91	0.77	4.59	1.79	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	221.68	1.12	3.37	0.45	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	151.49	0.86	6.90	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	259.33	1.90	4.27	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	268.99	2.11	5.62	1.40	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	151.63	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	138.30	0.43	2.89	0.29	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	84.56	2.03	3.22	1.53	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	78.83	0.64	2.26	0.97	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	127.77	0.00	1.79	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	128.23	0.70	3.14	0.70	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	153.55	1.32	3.52	0.44	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	168.66	1.26	5.06	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	83.11	2.29	4.16	1.25	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	67.49	2.00	2.67	1.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	298.86	1.63	7.89	1.63	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	311.92	0.00	1.61	3.75	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	193.67	1.79	5.38	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	161.88	0.74	3.15	0.37	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	115.67	1.08	1.08	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	106.97	0.42	2.73	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	164.32	0.51	2.53	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	154.24	0.00	1.73	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	265.85	1.31	4.36	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	242.98	0.49	2.47	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	161.56	0.92	2.77	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	167.50	1.40	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	232.90	1.11	3.88	0.83	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	267.48	0.98	6.87	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	178.64	0.00	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	226.69	1.07	3.94	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	186.97	0.00	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	223.61	2.29	2.95	1.64	0.33
CD8+ T Cells, donor2	11307-117C2	104.75	5.26	1.88	3.00	0.38
CD8+ T Cells, donor3	11383-118B6	180.53	3.28	2.78	4.80	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	137.18	9.41	10.09	4.59	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	133.96	9.35	8.39	4.07	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	148.29	12.86	9.03	3.83	2.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	196.94	9.01	10.21	3.60	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	135.59	11.28	7.68	6.00	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	127.11	4.09	6.59	1.59	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	121.68	6.74	7.82	3.04	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	111.07	5.26	9.21	1.84	2.11
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	120.31	6.80	8.44	3.52	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	134.34	8.75	7.85	4.83	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	126.37	8.13	5.52	4.94	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	110.84	4.26	7.46	4.00	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	81.42	0.00	1.75	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	83.80	0.46	2.73	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	47.74	0.00	6.71	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	154.15	3.96	12.25	0.72	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	145.01	4.03	8.06	2.88	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	132.93	1.41	7.31	1.41	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	158.14	7.61	11.09	4.12	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	139.02	4.61	10.15	2.15	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	141.70	4.81	8.66	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	138.84	3.06	9.94	1.91	1.91
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	119.41	3.94	5.91	2.36	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	118.00	6.05	10.59	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	80.30	2.41	8.03	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	96.52	2.80	5.60	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	121.21	9.02	9.02	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	118.80	3.66	5.48	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	63.24	0.49	2.47	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	133.75	0.32	5.26	0.42	0.11
Chondrocyte - de diff, donor1	11261-116G1	64.83	2.08	3.47	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	50.11	0.36	1.07	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	61.21	0.68	2.84	1.48	0.57
Chondrocyte - re diff, donor2	11339-117F7	130.71	0.90	6.27	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	38.01	1.62	1.21	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	119.46	0.57	7.46	0.46	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	72.68	0.43	3.85	1.07	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	79.29	0.71	4.69	1.68	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	73.54	0.83	4.40	0.37	0.28
Corneal Epithelial Cells, donor1	11526-119I5	16.25	0.00	1.76	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	23.89	0.00	4.55	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	25.31	0.00	2.56	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	68.51	0.66	1.65	0.50	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	64.66	0.95	2.21	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	59.39	0.86	1.73	0.76	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	163.65	0.68	2.73	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	165.18	0.65	3.92	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	131.15	0.48	1.94	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	46.70	0.17	1.50	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	36.38	0.00	2.35	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	40.44	0.28	2.55	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	31.85	0.00	2.36	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	32.29	0.00	2.91	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	76.23	0.94	3.29	2.12	0.71
Endothelial Cells - Artery, donor3	11413-118E9	54.17	0.18	1.93	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	70.49	0.22	1.55	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	73.02	0.61	2.74	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	65.12	0.00	1.69	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	27.63	0.00	0.59	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	47.38	0.52	5.21	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	18.01	0.28	0.43	0.57	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	106.43	0.00	8.80	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	23.59	0.00	1.57	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	135.55	0.75	8.70	0.37	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	59.31	0.65	2.17	0.87	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	72.06	0.37	5.13	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	39.81	0.00	3.41	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	23.75	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	36.58	0.94	2.20	0.31	0.00
Eosinophils, donor1	12244-129H3	198.21	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	28.05	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	24.97	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	18.08	0.00	2.69	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	52.55	0.82	0.82	1.64	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	38.98	1.97	2.41	0.99	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	65.22	2.82	3.68	1.52	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	109.15	0.49	8.49	1.33	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	108.77	0.14	9.69	0.27	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	60.01	0.63	2.21	0.84	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	63.50	0.53	2.37	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	71.42	0.33	6.31	1.99	1.00
Fibroblast - Cardiac, donor1	11268-116G8	57.16	0.91	2.72	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	44.72	0.76	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	36.91	0.63	2.05	0.63	0.47
Fibroblast - Cardiac, donor4	11452-119A3	131.55	0.30	4.24	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	74.87	0.38	4.19	0.89	0.13
Fibroblast - Cardiac, donor6	11460-119B2	64.28	0.45	3.18	0.91	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	30.55	0.13	1.34	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	70.32	0.00	3.02	1.73	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	77.63	2.93	5.86	2.93	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	58.81	0.00	3.92	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	139.92	0.85	3.05	1.02	0.85
Fibroblast - Dermal, donor1	11269-116G9	100.25	0.47	10.33	0.47	0.47
Fibroblast - Dermal, donor2	11346-117G5	95.28	0.94	4.25	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	116.29	2.06	7.37	2.18	1.09
Fibroblast - Dermal, donor4	11450-119A1	104.45	0.45	10.74	0.90	0.11
Fibroblast - Dermal, donor5	11454-119A5	117.23	0.87	9.25	1.05	0.35
Fibroblast - Dermal, donor6	11458-119A9	127.66	0.49	12.51	1.14	0.00
Fibroblast - Gingival, donor1	11237-116D4	120.15	0.42	8.95	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	61.31	0.00	3.41	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	98.97	1.58	7.78	2.90	0.53
Fibroblast - Gingival, donor3	11394-118C8	101.71	0.39	3.58	0.77	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	70.64	0.00	4.16	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	40.00	0.70	1.76	1.59	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	74.52	0.94	5.77	0.62	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	75.73	0.95	5.27	0.54	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	18.35	0.00	1.76	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	54.55	0.44	4.24	0.58	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	57.00	0.68	4.36	0.55	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	92.47	1.43	6.25	0.44	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	47.10	0.88	1.47	0.88	0.59
Fibroblast - Lung, donor1	11270-116H1	23.11	1.36	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	132.80	1.49	5.97	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	86.74	0.63	3.38	1.06	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	19.99	0.00	5.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.48	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	92.15	0.00	9.34	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	59.56	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	131.90	0.78	8.34	0.78	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	109.67	1.21	10.47	1.52	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	176.55	0.00	13.77	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	56.48	0.38	4.58	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	53.46	0.27	4.32	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	37.92	0.46	2.20	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	134.19	0.77	9.17	0.99	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	44.09	0.20	3.25	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	24.06	0.67	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	66.03	0.40	2.77	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	63.70	1.59	3.18	0.99	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	98.40	1.24	2.66	2.31	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	132.64	1.38	5.12	1.58	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	69.80	0.30	6.32	1.50	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	108.38	1.08	5.18	0.32	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	50.36	1.01	2.53	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	76.46	0.16	4.92	0.49	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	107.87	1.00	5.81	0.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	79.97	0.40	5.63	0.50	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	76.47	2.12	4.84	1.51	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	113.25	0.41	3.31	0.91	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	96.93	1.03	2.56	0.85	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	44.34	0.66	2.63	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	78.72	0.32	4.47	0.43	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	82.15	0.67	5.57	1.35	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	95.03	2.98	3.14	1.25	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1639.82	88.64	66.48	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	64.49	0.87	3.49	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	83.91	0.17	6.24	0.69	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	121.27	0.00	6.51	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	104.25	0.77	8.18	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	120.19	3.83	8.42	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	177.38	1.28	17.23	3.83	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	193.98	2.57	21.39	5.99	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	86.59	2.21	6.89	1.93	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	76.49	1.60	5.02	1.83	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	127.60	3.76	12.88	4.56	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	80.62	1.85	6.61	1.85	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	69.14	0.33	4.89	1.96	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	178.22	3.54	19.02	6.19	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	199.69	2.12	19.36	1.84	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	135.83	2.46	12.44	1.60	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	161.98	3.49	11.55	3.22	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	117.82	1.49	7.43	0.99	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	115.72	0.97	9.69	1.52	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	131.74	2.85	11.38	1.42	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	81.23	0.46	3.42	1.14	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	101.52	1.25	7.72	1.49	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	80.65	1.75	6.34	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	98.10	0.30	4.73	0.59	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	98.55	2.07	7.47	2.54	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	91.60	0.22	6.26	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	88.92	1.21	5.44	0.60	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	118.24	0.85	4.41	1.87	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	151.81	0.89	8.34	0.44	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	212.69	0.52	9.68	0.42	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	213.98	0.68	9.91	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	99.59	0.89	5.20	1.22	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	143.51	0.17	8.32	0.33	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	143.13	1.02	7.35	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	103.57	1.03	5.36	1.44	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	106.30	2.19	4.38	1.61	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	94.89	0.67	5.34	0.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	91.92	0.88	5.07	1.76	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	115.86	1.23	5.78	2.21	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	89.80	0.49	4.70	1.13	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	97.50	0.32	4.49	0.96	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	77.13	1.23	4.07	1.14	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	89.21	0.32	5.06	1.11	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	83.32	1.52	3.04	2.43	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	74.33	0.84	3.76	0.63	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	88.04	1.10	3.73	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	63.12	0.56	2.52	1.12	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	64.63	0.83	3.98	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	85.30	2.67	5.08	2.14	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	87.06	0.92	4.74	1.07	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	72.54	1.04	3.11	1.04	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	67.23	0.54	3.52	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	72.82	1.47	3.13	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	69.30	0.66	2.63	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	84.30	0.99	1.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	59.36	0.26	1.32	0.79	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	51.04	0.61	1.61	1.01	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	149.70	0.00	5.85	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	307.55	1.59	27.47	1.19	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	216.94	3.54	15.41	2.16	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	274.96	3.68	21.48	2.66	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	144.57	1.25	13.77	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	162.19	0.57	14.41	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	138.82	5.53	10.15	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	148.49	4.95	12.37	7.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	168.65	0.77	13.15	5.03	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	104.29	1.60	8.02	8.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	113.02	8.69	8.69	8.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	120.75	1.95	8.46	5.21	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	163.49	1.65	11.53	4.12	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	123.29	16.66	13.33	13.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	116.05	1.96	9.51	3.36	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	133.03	2.61	8.82	3.92	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	111.57	8.39	5.87	5.87	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	128.18	1.59	7.95	5.41	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	129.75	0.34	10.19	3.06	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	89.79	2.09	2.09	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	115.11	3.44	8.59	3.44	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	78.73	1.18	2.96	1.78	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	113.51	8.47	8.47	10.16	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	134.62	3.73	10.36	5.38	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	126.34	1.84	8.05	4.60	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	5.27	0.00	15.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	89.18	0.77	5.77	2.69	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	98.77	0.98	4.89	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	76.92	1.34	6.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	130.22	1.93	6.16	3.08	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	197.53	3.42	7.53	3.77	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	4.97	7.45	4.97	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	123.62	2.36	8.02	6.13	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	83.89	3.02	4.83	2.41	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	102.75	0.00	5.60	1.53	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	126.83	2.79	7.18	2.79	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	139.13	1.97	6.41	4.44	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	115.68	8.26	4.72	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	101.52	2.33	4.08	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	124.20	2.19	5.71	4.39	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	102.57	1.70	2.54	2.54	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	66.26	1.19	1.19	2.39	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	82.98	1.46	3.88	1.46	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	28.53	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	34.51	0.42	0.42	2.49	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	32.61	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	73.26	2.85	4.12	1.27	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	46.79	0.42	3.34	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	198.78	1.97	17.17	3.13	1.28
Hep-2 cells mock treated, biol_rep2	11899-125E9	194.97	2.19	16.88	3.88	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	213.17	2.50	18.88	3.64	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	186.70	3.39	13.66	3.28	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	200.94	1.50	19.56	2.36	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	199.35	2.80	21.31	3.23	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	197.27	2.49	13.70	3.74	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	177.38	1.54	14.24	2.57	1.20
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	187.10	1.60	18.90	4.49	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	19.03	0.00	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.49	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	23.28	0.35	2.47	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.80	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	81.13	1.40	6.47	1.05	0.00
Hepatocyte, donor1	11523-119I2	39.95	2.42	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	82.95	0.00	2.15	1.08	0.00
Hepatocyte, donor3	11684-122I1	51.54	4.91	0.61	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	105.08	1.31	6.53	1.96	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	143.32	1.40	3.67	1.05	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	125.96	1.65	6.86	0.55	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	0.00	15.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	65.07	0.00	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	0.00	2.50	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	66.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	74.72	1.62	8.12	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	63.36	0.00	3.33	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	68.98	0.00	10.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	58.23	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	78.71	0.00	5.54	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	57.62	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	87.55	0.63	8.19	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	51.04	0.00	7.73	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	81.40	1.94	3.88	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	48.30	0.00	9.66	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	70.08	0.81	7.33	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	50.80	0.42	7.14	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	28.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	71.53	0.00	3.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	56.32	0.92	8.31	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	64.67	0.47	6.14	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	70.74	0.00	2.72	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	60.26	0.00	3.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	62.25	0.00	5.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	49.74	0.00	5.10	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	47.39	0.00	7.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	73.55	0.71	9.28	2.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	96.61	0.62	6.79	1.23	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	0.00	12.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	75.44	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	38.94	0.00	8.34	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	66.39	0.00	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	61.60	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	32.26	0.00	2.62	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	49.50	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	45.87	0.00	2.13	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	48.49	0.00	5.54	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	39.89	0.00	8.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	46.94	0.00	2.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	36.30	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	41.24	0.00	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	95.80	0.24	10.20	0.57	0.00
Keratinocyte - epidermal, donor2	11349-117G8	59.73	0.00	4.10	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	98.92	1.51	6.82	2.37	1.14
Keratinocyte - oral, donor1	11251-116E9	261.32	2.27	20.89	2.27	0.91
Keratocytes, donor1	11527-119I6	52.26	0.34	2.06	0.69	0.34
Keratocytes, donor2	11607-120I5	9.37	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	99.19	1.58	5.53	2.57	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	35.17	2.20	6.59	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	72.28	1.08	4.31	3.24	1.08
Lens Epithelial Cells, donor2	11609-120I7	122.02	0.35	5.07	0.69	0.00
Lens Epithelial Cells, donor3	11690-122I7	85.77	0.40	4.94	0.91	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	71.74	0.36	3.32	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	38.79	1.12	2.23	0.84	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	61.23	1.10	1.42	3.31	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	39.25	0.54	2.69	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	30.26	0.95	0.95	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	37.95	0.97	1.40	0.75	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	44.73	0.41	2.46	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	25.53	1.26	1.01	1.01	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	39.55	1.27	2.11	1.69	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	49.84	0.40	1.98	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	46.53	0.97	1.74	1.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	22.40	0.37	0.37	0.74	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	46.34	1.05	1.39	1.39	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	40.07	0.95	1.91	0.95	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.39	0.55	1.24	1.92	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	56.66	0.62	3.08	2.16	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	28.37	0.31	0.94	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	36.96	0.91	0.73	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	49.37	0.99	2.63	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	31.04	0.59	1.46	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	21.66	0.00	0.50	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	53.83	0.97	2.42	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	49.82	0.81	1.08	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	39.06	0.61	1.06	0.76	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	47.18	0.00	2.07	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	54.44	2.09	2.30	1.05	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	35.04	0.90	0.75	1.20	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	56.41	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	46.85	0.75	1.51	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	25.87	0.64	0.95	0.85	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	48.94	0.97	2.42	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	43.66	0.99	3.97	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	25.77	0.62	0.62	1.24	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	48.13	0.74	2.96	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	49.91	1.48	1.24	0.99	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	26.40	0.96	1.10	1.24	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	53.39	0.64	1.61	1.29	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	66.04	0.91	3.04	1.22	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	47.31	1.12	1.68	2.10	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	56.53	0.71	1.78	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	30.54	0.48	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	20.07	0.16	0.31	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	49.06	0.72	2.86	1.43	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	35.28	0.33	1.31	0.33	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	22.84	0.24	0.71	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	82.54	0.50	3.59	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	29.97	0.51	1.02	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	30.13	0.30	1.19	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	54.38	0.00	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	49.10	1.53	1.53	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	58.64	2.97	5.20	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	46.54	0.85	2.12	1.69	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	47.83	1.41	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	38.29	0.93	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	54.10	0.52	2.58	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	35.68	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	60.85	0.23	2.49	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	74.74	1.16	4.07	1.74	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	90.94	2.25	4.05	2.25	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	80.07	0.68	3.52	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	53.41	1.03	0.51	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	77.98	1.06	3.18	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	71.29	0.00	4.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	52.47	2.04	2.55	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	102.99	0.27	4.00	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	82.76	1.89	3.40	1.70	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	47.24	1.23	3.68	2.45	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	73.39	0.82	4.08	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	86.21	1.67	1.87	2.50	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	79.03	3.36	3.36	5.89	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	60.79	0.00	4.12	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	73.74	2.90	2.32	2.03	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	75.93	2.09	4.78	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	85.20	0.00	2.21	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	60.09	1.41	1.77	1.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	73.02	0.74	3.32	2.21	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	63.32	0.00	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	61.40	1.15	1.54	0.77	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	66.80	0.57	4.53	2.83	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	59.89	0.00	3.28	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	46.09	0.45	4.97	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	55.30	2.87	3.59	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	82.91	0.00	3.73	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	56.11	1.86	1.49	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	56.43	1.29	4.31	1.72	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	59.08	2.57	2.57	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	75.30	0.67	2.00	2.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	42.83	1.81	3.02	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	42.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	55.34	0.34	1.72	1.03	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	53.14	2.15	4.29	2.68	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	47.14	1.35	4.04	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	61.12	1.48	1.85	3.70	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	67.45	0.00	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	35.96	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	54.42	0.80	3.60	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	24.71	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	49.06	1.53	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	53.27	1.48	0.99	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	42.34	0.00	3.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	50.78	0.50	3.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	60.38	0.90	0.90	1.35	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	48.19	0.00	1.72	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	73.48	0.89	3.12	1.78	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	62.56	0.78	3.52	1.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	47.50	1.32	2.64	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	71.61	1.56	1.04	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	87.08	1.75	2.63	4.81	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	77.16	1.68	4.47	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	78.17	2.65	3.97	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	77.91	1.16	3.09	3.09	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	77.47	1.01	3.54	3.04	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	81.71	0.48	3.84	1.92	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	87.86	1.99	3.98	1.19	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	72.91	1.82	4.86	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	51.88	1.38	2.08	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	76.38	1.90	2.28	3.04	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	80.04	0.00	3.61	1.03	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	62.28	1.81	3.63	2.42	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	71.94	2.85	3.49	1.90	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	69.30	2.13	3.73	1.60	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	70.11	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	76.11	2.06	3.09	5.66	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	79.22	2.12	0.71	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	64.13	0.57	1.70	2.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	74.88	1.66	2.50	1.66	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	75.17	0.78	2.35	2.35	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	65.55	0.00	2.09	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	81.31	1.39	3.25	2.32	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	80.29	0.67	1.34	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	74.32	0.00	4.81	4.28	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	96.58	1.21	5.25	3.64	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	47.72	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	63.13	0.89	0.89	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	81.49	0.00	2.28	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	62.12	0.77	3.83	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	68.40	1.64	1.09	1.09	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	82.41	0.00	4.01	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	92.02	1.30	2.08	0.78	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	58.35	0.00	1.33	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	56.12	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	48.77	0.23	0.68	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	81.66	0.37	2.20	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	46.14	0.39	0.92	0.39	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	84.96	0.00	8.50	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	80.65	0.48	4.60	0.16	0.48
Mallassez-derived cells, donor3	11930-125I4	160.81	0.42	12.79	0.97	0.28
Mammary Epithelial Cell, donor1	11273-116H4	228.58	1.59	18.04	1.79	1.49
Mammary Epithelial Cell, donor2	11350-117G9	218.32	2.03	19.98	3.76	1.16
Mammary Epithelial Cell, donor3	11422-118F9	34.42	1.00	3.49	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	428.46	0.00	13.56	0.00	0.00
Mast cell, donor1	11563-120D6	100.14	0.22	2.81	0.00	0.11
Mast cell, donor2	11565-120D8	117.38	0.00	3.86	0.89	0.00
Mast cell, donor3	11566-120D9	145.43	0.68	2.93	1.13	0.00
Mast cell, donor4	11567-120E1	114.35	0.53	2.84	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	119.99	0.67	3.22	0.22	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	86.97	0.58	1.17	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	65.62	0.34	1.15	0.11	0.11
Mast cell, expanded, donor8	11941-126A6	51.72	0.33	0.67	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	102.98	0.90	3.68	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	58.14	0.00	5.19	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	95.84	0.22	6.45	0.43	0.36
Melanocyte - light, donor1	11274-116H5	16.93	0.00	2.12	0.00	0.00
Melanocyte - light, donor2	11351-117H1	14.33	0.68	1.36	0.00	0.00
Melanocyte - light, donor3	11423-118G1	26.02	0.87	0.00	3.47	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	94.65	0.73	4.27	1.04	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	76.65	1.08	4.30	1.61	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	75.00	0.27	3.75	0.80	0.00
Meningeal Cells, donor1	11493-119E8	66.12	0.00	5.21	0.00	0.00
Meningeal Cells, donor2	11573-120E7	52.82	0.00	3.52	0.00	0.00
Meningeal Cells, donor3	11654-122E7	176.86	1.22	13.94	0.49	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	112.07	0.57	11.12	0.00	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	92.78	0.30	3.42	0.30	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	20.93	0.00	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	98.31	4.31	9.33	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	68.19	0.85	1.69	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	57.30	0.50	2.01	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	33.40	0.00	4.61	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	32.88	0.73	2.92	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	23.94	0.20	4.09	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	97.51	1.39	6.23	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	15.61	0.37	0.74	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	127.63	1.18	3.16	1.18	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	23.44	0.30	1.48	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	27.54	0.00	3.84	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	164.11	1.06	23.39	0.35	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	119.46	0.63	5.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	98.69	0.00	9.43	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	80.61	0.27	3.18	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	45.54	0.50	3.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	48.85	1.73	1.66	1.16	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	31.06	0.00	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	65.51	0.74	1.97	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	62.72	1.18	4.12	0.88	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	63.54	1.55	0.93	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	54.97	1.87	3.53	0.83	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	58.56	0.75	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	48.88	1.40	3.26	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	55.88	1.02	1.42	0.41	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	51.08	1.58	3.17	0.79	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	59.29	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	60.41	1.90	3.04	1.14	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	1.32	5.26	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	53.69	1.70	2.33	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	22.10	0.00	4.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	46.20	1.49	1.49	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	57.21	1.51	2.51	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	46.82	1.19	2.85	1.19	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	17.14	0.00	2.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	56.87	0.69	2.53	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	49.85	1.05	3.16	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	40.56	0.00	2.24	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	61.57	0.86	2.79	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	40.23	0.67	2.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	38.33	0.44	2.19	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	26.36	0.51	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	40.23	0.82	1.90	1.09	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	36.47	0.00	2.65	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	34.60	0.00	0.96	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	32.82	1.20	1.60	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	0.00	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	42.05	0.50	3.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	48.17	0.44	1.75	1.31	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	18.57	0.00	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	59.00	0.50	3.47	0.99	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.22	0.70	2.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	49.57	0.34	2.39	1.03	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	18.82	0.88	1.31	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	17.04	0.36	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	61.44	1.40	1.12	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	30.76	0.42	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	22.73	0.58	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	41.63	1.21	1.51	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	49.67	1.25	1.25	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	25.86	0.00	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	45.53	1.14	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	40.21	0.14	0.97	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	54.42	0.52	2.59	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	37.32	0.43	1.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.06	1.27	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	34.70	0.53	2.40	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	43.40	0.90	3.89	0.90	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	30.79	0.42	0.71	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	49.69	0.00	0.64	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	57.94	0.66	2.65	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	34.13	0.00	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	64.78	0.28	1.70	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	56.53	0.25	1.72	1.47	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	29.33	0.65	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	51.45	0.88	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	54.21	0.58	2.02	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	66.77	0.00	1.65	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	33.05	1.79	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	55.25	1.78	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	62.76	2.30	1.31	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	39.97	1.05	0.00	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	45.86	0.40	1.78	0.20	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	55.88	0.93	2.79	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	56.33	0.75	1.88	0.38	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	39.42	0.27	0.27	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	63.00	0.11	1.47	0.34	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	50.83	1.47	1.47	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	47.64	0.73	1.47	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	57.56	1.56	1.56	9.33	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	89.25	0.00	2.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	44.44	3.03	0.00	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	40.06	1.26	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	93.97	0.00	1.36	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	112.54	0.00	2.54	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	89.08	0.00	0.81	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	42.29	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	205.57	0.00	22.84	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	274.05	0.00	35.89	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	118.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	74.97	0.22	4.52	1.08	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	50.17	2.61	1.57	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	29.37	1.33	2.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.94	0.83	1.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	63.89	1.14	6.85	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	46.28	0.00	7.98	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.72	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	277.48	0.00	22.05	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	16.32	0.84	1.67	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	29.52	0.23	2.32	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.08	0.27	0.81	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	37.84	0.42	3.36	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	879.64	33.40	89.08	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	26.80	0.00	1.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	31.94	1.35	0.54	1.08	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	28.34	1.13	1.36	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.29	0.16	1.80	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	58.14	0.55	2.37	1.46	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	35.01	0.53	1.59	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	24.01	1.20	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	94.19	0.66	2.95	0.66	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.60	0.65	0.49	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	68.26	0.53	4.06	2.12	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	30.94	2.81	0.70	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	26.20	0.46	0.92	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	38.24	0.32	1.61	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	101.74	2.76	2.41	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	477.88	7.59	15.17	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	51.69	0.45	2.23	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	25.83	0.00	1.27	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	33.94	1.19	1.90	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	33.91	0.43	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1146.53	18.06	27.08	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	33.32	0.33	1.33	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.44	0.45	2.71	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	25.00	0.00	1.19	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	29.72	0.93	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	36.32	0.38	1.51	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.81	0.65	1.30	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	23.53	0.00	0.87	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	43.87	0.90	2.26	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	29.98	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	27.92	1.33	0.66	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	42.66	1.49	3.47	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	23.74	0.38	1.15	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	42.04	1.21	1.51	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	47.30	0.22	2.21	1.77	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	30.49	0.00	2.71	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	388.32	5.11	25.55	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	35.36	0.00	1.83	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	23.29	0.00	0.94	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	34.20	0.91	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.94	0.79	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	89.56	2.27	2.27	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	455.21	0.00	20.23	0.00	0.00
Myoblast, donor1	11241-116D8	107.83	1.49	11.06	0.99	0.12
Myoblast, donor2	11322-117D8	75.76	1.34	6.52	0.19	0.58
Myoblast, donor3	11398-118D3	98.88	0.17	7.74	0.67	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	121.85	1.61	2.77	1.90	0.44
Natural Killer Cells, donor1	11230-116C6	174.98	2.77	3.38	2.15	1.23
Natural Killer Cells, donor2	11311-117C6	109.46	3.02	3.02	5.13	1.21
Natural Killer Cells, donor3	11387-118C1	118.71	3.13	0.92	1.66	0.92
Neural stem cells, donor1	11275-116H6	122.31	0.73	7.98	0.00	0.36
Neural stem cells, donor2	11352-117H2	152.13	0.00	15.41	0.00	0.00
Neurons, donor1	11494-119E9	120.62	2.28	4.55	0.00	0.00
Neurons, donor2	11574-120E8	86.96	0.88	5.06	0.00	0.44
Neurons, donor3	11655-122E8	83.86	2.47	4.11	2.47	0.82
Neutrophils, donor1	11233-116C9	5.57	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	11.60	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	9.16	0.00	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	154.59	0.95	4.87	2.61	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	25.72	1.63	2.60	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	63.98	0.40	3.01	0.60	0.00
Olfactory epithelial cells, donor1	11933-125I7	46.39	1.10	1.79	1.24	0.28
Olfactory epithelial cells, donor2	11934-125I8	65.28	1.16	2.46	2.61	1.16
Olfactory epithelial cells, donor3	11935-125I9	53.69	0.68	1.25	1.36	0.34
Olfactory epithelial cells, donor4	11936-126A1	55.91	0.97	2.92	1.56	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	123.37	0.60	9.03	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	56.79	0.00	2.77	0.64	0.00
Osteoblast - differentiated, donor2	11353-117H3	36.58	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	56.48	1.24	1.86	0.00	0.00
Osteoblast, donor1	11277-116H8	44.95	0.00	2.15	0.39	0.00
Osteoblast, donor2	11354-117H4	122.20	2.11	11.24	0.00	2.11
Osteoblast, donor3	11426-118G4	46.74	0.18	4.27	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	126.02	0.76	8.76	1.01	0.34
Pericytes, donor1	11491-119E6	10.01	0.00	0.45	0.00	0.00
Pericytes, donor2	11571-120E5	7.92	0.00	0.45	0.00	0.00
Pericytes, donor3	11652-122E5	24.82	0.81	1.63	0.20	0.20
Perineurial Cells, donor1	11499-119F5	134.04	0.79	7.12	1.13	0.11
Perineurial Cells, donor2	11579-120F4	118.97	0.55	4.97	0.83	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	186.78	0.64	3.19	1.27	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	86.44	0.73	1.22	2.45	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	105.21	1.04	1.29	1.16	0.13
Placental Epithelial Cells, donor1	11278-116H9	52.38	0.48	3.83	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	28.83	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	29.06	0.39	1.18	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	22.78	1.58	0.32	1.58	0.00
Preadipocyte - breast, donor1	11467-119B9	54.96	0.56	3.00	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	61.87	0.26	3.13	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	43.68	0.45	2.48	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	67.88	0.21	4.37	0.11	0.21
Preadipocyte - omental, donor2	11329-117E6	65.03	0.87	4.80	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	59.16	0.72	3.01	1.29	0.29
Preadipocyte - perirenal, donor1	11469-119C2	28.54	0.00	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	28.56	0.00	4.61	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	142.02	3.36	11.86	2.12	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	90.08	0.51	6.81	1.19	0.00
Preadipocyte - visceral, donor1	11280-116I2	161.05	0.93	18.07	0.93	0.37
Preadipocyte - visceral, donor2	11357-117H7	88.81	0.00	6.90	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	77.11	0.52	6.37	1.46	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	201.84	0.91	8.90	1.36	1.06
Prostate Epithelial Cells, donor2	11331-117E8	47.80	0.54	5.15	0.54	0.41
Prostate Epithelial Cells, donor3	11404-118D9	117.94	3.00	7.04	4.65	1.71
Prostate Stromal Cells, donor1	11254-116F3	135.31	1.03	10.82	1.59	0.46
Prostate Stromal Cells, donor2	11332-117E9	108.48	2.69	7.35	5.02	1.79
Prostate Stromal Cells, donor3	11405-118E1	52.66	0.52	3.55	1.56	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.91	0.00	3.65	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	91.49	0.35	7.76	0.35	0.28
Renal Epithelial Cells, donor1	11517-119H5	15.72	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	8.54	0.00	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	105.76	1.38	8.26	1.48	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	23.72	0.40	1.89	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	71.04	3.33	7.10	1.78	1.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	0.67	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	23.11	0.00	2.42	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	18.81	0.00	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	6.94	0.00	0.83	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	59.32	0.27	5.10	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	23.61	0.42	5.06	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	21.41	0.00	1.93	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	148.31	0.78	8.04	1.04	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	49.17	0.28	2.84	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	15.44	1.03	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	139.50	0.00	15.31	0.50	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	114.26	0.67	1.60	1.20	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	75.05	0.89	4.47	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	200.89	3.30	3.85	6.05	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	160.68	1.16	6.96	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	135.62	0.39	7.80	0.91	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	99.31	1.99	6.36	2.18	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	145.11	1.00	13.61	0.45	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	202.81	1.61	9.18	3.60	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	118.29	0.82	6.29	3.03	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	142.15	2.77	9.71	2.77	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	101.04	1.23	4.79	1.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	128.13	2.12	6.50	1.51	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	111.81	0.72	7.35	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	107.16	1.29	3.87	2.73	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	106.99	1.18	6.65	2.36	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	113.29	0.89	6.64	2.43	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	99.03	0.96	5.93	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	113.85	1.02	7.08	1.02	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	162.54	2.07	10.52	1.13	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	92.89	0.13	5.97	1.06	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	128.98	1.85	7.30	2.04	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	129.28	1.91	6.49	1.53	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	104.98	0.75	5.23	1.50	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	106.80	1.96	5.05	2.24	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	114.33	3.25	8.37	1.71	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	80.41	1.09	7.11	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	109.63	1.96	5.03	1.84	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	120.62	2.15	9.27	2.15	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	146.01	0.94	5.66	2.83	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	125.40	1.59	4.76	2.78	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	119.73	2.10	6.55	1.40	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	121.51	0.21	5.18	2.07	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	136.93	1.11	9.07	3.98	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	103.19	1.04	7.10	1.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	115.20	1.35	5.92	1.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	114.27	0.85	9.03	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	111.24	2.31	6.17	0.58	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	127.06	1.20	6.02	1.89	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	87.79	1.23	7.54	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	116.07	2.63	6.40	3.28	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	95.10	0.51	2.05	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	123.10	0.89	4.73	2.07	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	94.89	0.53	4.53	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	83.51	0.97	4.29	1.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	100.48	1.43	4.52	2.14	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	109.44	1.41	5.04	1.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	78.16	0.75	2.35	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	111.80	3.14	2.79	3.49	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	102.15	2.12	4.53	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	79.80	0.37	1.59	1.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	141.19	0.87	4.37	0.44	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	98.57	0.00	3.65	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	68.42	0.30	3.01	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	81.43	1.58	3.62	2.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	82.07	0.90	2.10	1.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	102.13	0.83	3.66	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	74.28	1.07	2.13	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	74.52	0.00	3.00	1.20	0.00
Schwann Cells, donor1	11498-119F4	14.11	0.00	1.32	0.56	0.00
Schwann Cells, donor2	11578-120F3	78.26	3.40	10.21	3.40	0.00
Schwann Cells, donor3	11659-122F3	51.92	0.88	3.07	2.19	0.66
Sebocyte, donor1	11220-116B5	143.52	0.55	12.05	0.00	0.00
Sebocyte, donor2	11301-117B5	74.45	0.92	6.43	0.46	0.00
Sebocyte, donor3	11378-118B1	54.00	0.21	2.89	0.00	0.00
Sertoli Cells, donor1	11255-116F4	114.31	0.00	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	84.73	0.00	0.00	8.47	0.00
Skeletal Muscle Cells, donor1	11281-116I3	146.57	0.62	7.39	0.79	0.18
Skeletal Muscle Cells, donor2	11358-117H8	17.35	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	40.13	0.00	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	111.85	0.63	10.84	1.26	0.63
Skeletal Muscle Cells, donor5	11455-119A6	90.82	0.89	7.88	0.45	0.15
Skeletal Muscle Cells, donor6	11459-119B1	140.21	1.08	15.70	0.62	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	149.19	0.63	9.83	1.39	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	79.05	1.57	6.85	1.00	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	121.04	1.49	13.59	1.69	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	136.49	0.51	6.15	1.01	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	47.77	0.72	3.62	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	26.83	0.55	1.24	0.00	0.00
Skin - palm, donor1	10286-104F7	32.23	2.69	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	51.75	1.73	4.76	1.59	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	85.06	1.64	8.18	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	64.52	1.43	4.54	0.78	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	147.77	0.70	17.93	2.09	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	81.30	1.27	4.78	1.83	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	122.64	0.85	11.84	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	90.69	1.20	5.55	1.57	0.67
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	54.62	0.31	4.01	2.16	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	44.91	0.44	3.11	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	45.85	0.59	2.35	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	43.09	0.22	1.77	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	48.04	0.00	1.97	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	50.99	0.00	5.41	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	79.06	1.00	3.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	44.71	0.00	3.46	0.27	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	89.99	1.77	5.10	1.99	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	67.47	0.26	6.53	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	71.63	0.33	6.51	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	93.32	0.30	5.02	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	44.84	0.14	2.70	0.43	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	16.27	0.00	0.49	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	73.06	3.04	5.78	2.74	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	44.70	0.51	1.77	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	22.41	0.00	2.86	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	62.82	0.00	3.83	0.44	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	53.81	0.65	3.87	1.29	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	74.31	1.57	5.56	0.63	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	49.34	0.31	3.87	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	39.88	0.00	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	46.62	0.00	2.99	1.20	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	25.95	0.00	1.02	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	147.87	0.86	4.55	1.33	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	105.07	0.50	12.18	0.20	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	80.33	0.68	4.78	1.59	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	30.79	0.00	1.81	2.42	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	299.90	3.18	31.26	2.12	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	76.30	0.00	5.19	0.93	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	76.01	1.13	5.01	2.25	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	66.97	0.25	2.54	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	80.81	0.30	4.98	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.01	1.50	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	40.00	0.00	1.86	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	53.01	1.01	4.54	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	48.26	0.31	2.82	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.12	0.00	2.06	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	182.69	0.33	16.83	0.75	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	42.98	0.00	1.87	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	37.71	0.00	2.16	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	47.17	0.25	1.78	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	30.46	0.38	2.07	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	155.54	0.56	12.16	0.56	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	137.83	0.25	6.95	0.34	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	15.24	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	37.92	0.24	1.22	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	112.68	0.22	9.06	1.77	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	80.46	0.88	7.61	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.79	0.97	0.97	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	39.93	0.79	2.38	1.59	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	80.34	0.74	4.09	1.12	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	54.62	2.16	3.95	0.72	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	47.70	0.85	7.67	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	79.96	0.79	7.09	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	56.89	2.29	2.79	0.51	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	27.95	0.00	1.60	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	36.78	0.42	2.09	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	51.79	0.00	1.38	0.00	0.92
Synoviocyte, donor1	11291-117A4	73.56	1.01	2.02	0.84	0.00
Synoviocyte, donor2	11368-117I9	58.17	1.51	1.51	0.84	0.67
Synoviocyte, donor3	11440-118H9	46.02	0.67	1.56	1.56	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	36.81	0.00	3.22	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	51.53	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	23.15	0.23	2.08	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	85.95	0.22	7.03	0.07	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	27.06	0.00	3.09	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	28.63	0.00	2.86	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	110.72	0.37	2.71	0.86	0.25
Urethra, donor2	10319-105A4	55.75	5.40	7.19	0.00	0.00
Urothelial Cells, donor1	11520-119H8	20.46	0.00	1.06	0.00	0.00
Urothelial Cells, donor2	11600-120H7	15.62	0.40	2.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	12.84	0.00	0.69	0.23	0.00
Urothelial cells, donor0	11216-116B1	127.27	0.00	5.13	1.56	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	69.40	0.89	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	57.18	0.00	4.29	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	49.29	1.37	0.68	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	122.24	0.00	3.44	0.69	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	105.75	0.00	2.32	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	46.86	0.00	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	57.82	0.92	1.84	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	42.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	160.25	1.48	10.98	1.36	0.86
Wilms' tumor cell line:HFWT	10597-108E3	76.56	2.64	2.64	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	120.39	1.68	7.26	1.40	1.12
achilles tendon, donor2	10292-104G4	45.46	2.07	6.20	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	230.48	2.80	12.49	4.08	3.06
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	313.67	1.39	11.84	2.32	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	259.14	1.19	9.73	1.19	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	272.66	2.99	19.86	4.35	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	223.46	7.31	10.40	6.75	3.09
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	164.96	1.06	3.60	1.06	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	241.72	5.44	10.34	1.63	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	152.46	1.76	6.61	0.88	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	208.26	4.90	6.13	2.86	2.45
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	293.55	5.82	9.32	4.66	4.27
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	215.83	7.54	18.03	3.50	1.84
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	273.04	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	286.53	6.97	15.10	5.11	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	284.79	6.47	15.53	3.37	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	240.22	6.14	13.44	10.81	3.80
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	96.67	0.93	6.97	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	90.89	1.23	4.52	0.41	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	46.66	1.53	2.76	0.92	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	258.16	2.99	9.81	1.28	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	221.71	0.91	13.65	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	265.74	0.72	11.79	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	165.27	2.67	14.48	3.34	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	134.09	1.33	17.01	0.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	219.27	1.86	13.01	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	244.45	2.64	27.12	1.13	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	173.14	0.87	6.54	1.31	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	138.71	0.00	13.12	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	132.59	0.71	4.00	1.65	0.94
adipose tissue, adult, pool1	10010-101C1	129.99	0.47	1.86	0.62	0.00
adipose, donor1	10184-103D4	170.65	0.59	12.90	2.35	0.59
adipose, donor2	10185-103D5	53.53	1.22	4.46	1.62	0.41
adipose, donor3	10186-103D6	65.89	1.91	5.99	1.09	0.54
adipose, donor4	10187-103D7	130.01	1.73	6.93	6.93	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	171.23	0.95	20.04	0.95	0.63
adrenal gland, adult, pool1	10081-102A9	65.48	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	130.60	0.67	7.20	0.67	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	118.98	0.36	6.43	2.14	1.07
amniotic membrane cells, donor1	12235-129G3	74.42	0.70	1.85	0.70	0.46
amniotic membrane cells, donor2	12236-129G4	58.15	0.34	3.38	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	73.06	0.88	1.47	1.18	0.00
amygdala - adult, donor10196	10167-103B5	47.43	1.19	4.74	0.00	0.00
amygdala, adult, donor10252	10151-102I7	64.48	2.64	4.66	1.22	0.61
amygdala, newborn, donor10223	10360-105E9	54.55	0.97	10.01	0.97	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	190.87	2.16	5.73	0.76	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	166.13	2.43	9.93	1.54	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	144.30	1.00	2.34	2.34	0.67
aorta, adult, pool1	10052-101G7	45.90	0.98	0.39	0.59	0.59
appendix, adult	10189-103D9	77.62	0.00	3.10	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	187.44	1.38	7.57	4.13	1.72
artery, adult	10190-103E1	81.52	2.72	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	113.43	0.43	3.48	0.87	0.14
b cell line:RPMI1788	10427-106D4	228.26	0.89	17.25	1.04	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	72.14	0.28	3.88	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	144.18	0.50	10.02	0.99	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	293.92	2.68	5.52	1.67	1.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	149.88	1.68	4.47	2.80	0.56
bladder, adult, pool1	10011-101C2	157.20	0.98	2.06	1.30	0.33
blood, adult, pool1	10053-101G8	57.58	0.00	2.21	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	47.96	0.00	2.57	0.86	0.00
bone marrow, adult	10192-103E3	97.17	4.05	4.05	1.35	1.35
brain, adult, donor1	10084-102B3	27.68	0.00	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	70.38	0.67	4.79	0.89	0.22
brain, fetal, pool1	10085-102B4	61.44	0.00	8.01	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	186.66	3.30	6.94	1.98	2.64
breast carcinoma cell line:MDA-MB-453	10419-106C5	198.72	0.25	6.12	0.37	0.25
breast, adult, donor1	10080-102A8	60.61	0.63	1.89	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	171.37	3.18	19.82	3.30	2.29
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	145.02	2.47	4.33	0.31	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	110.28	0.92	12.43	0.92	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	98.05	1.69	3.15	1.21	0.97
carcinoid cell line:NCI-H1770	10703-109H1	129.30	0.47	12.69	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	128.41	1.09	6.23	1.20	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	154.33	3.17	9.19	4.12	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	119.78	3.19	5.86	5.86	1.60
caudate nucleus - adult, donor10196	10177-103C6	47.20	1.15	5.76	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	70.78	0.67	3.18	1.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	42.79	1.53	8.41	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	72.51	0.00	4.39	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	87.40	0.00	20.39	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	115.30	1.71	6.83	0.85	0.21
cerebellum, adult, pool1	10083-102B2	42.08	1.03	5.86	1.03	0.34
cerebellum, newborn, donor10223	10357-105E6	73.90	3.32	5.81	0.00	0.00
cerebral meninges, adult	10188-103D8	71.86	0.50	6.56	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	38.74	0.00	2.92	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	488.14	1.29	13.37	1.58	1.58
cervical cancer cell line:ME-180	10553-107I4	204.66	0.99	6.79	1.82	0.17
cervix, adult, pool1	10013-101C4	145.41	0.63	3.57	0.84	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	111.33	0.56	4.74	0.56	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	26.13	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	194.37	0.75	13.17	1.86	0.62
choriocarcinoma cell line:SCH	10785-110H2	101.53	1.48	3.33	2.09	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	131.87	0.24	8.06	0.71	0.24
chorionic membrane cells, donor1	12238-129G6	61.83	0.57	1.71	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	80.34	0.89	3.18	0.60	0.30
chorionic membrane cells, donor3	12240-129G8	89.57	2.20	0.55	4.95	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	92.90	2.02	4.04	3.03	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	195.94	2.31	11.72	0.38	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	165.15	0.84	9.29	2.32	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	220.59	1.80	16.95	1.03	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	225.67	2.18	18.14	1.21	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	241.48	2.24	16.29	1.22	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	367.19	2.36	27.38	2.65	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	361.75	1.56	14.86	0.78	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	105.15	3.43	6.40	3.20	1.37
clear cell carcinoma cell line:TEN	10636-108I6	190.34	1.56	5.73	1.74	1.39
colon carcinoma cell line:CACO-2	10513-107D9	186.34	0.18	8.42	0.37	0.00
colon carcinoma cell line:COLO-320	10420-106C6	641.96	3.42	25.85	1.14	1.90
colon, adult, donor1	10082-102B1	24.99	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	110.34	0.71	1.76	0.47	0.47
colon, fetal, donor1	10070-101I7	72.92	0.62	3.09	3.09	0.62
common myeloid progenitor CMP, donor1	12130-128D6	96.25	0.00	13.75	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	230.31	1.27	12.32	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	240.89	1.51	13.13	0.75	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	263.69	1.69	15.09	0.71	0.71
corpus callosum, adult, pool1	10042-101F6	72.53	0.22	3.76	0.11	0.11
cruciate ligament, donor2	10295-104G7	51.87	1.62	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	56.98	0.00	0.80	1.61	0.80
diencephalon, adult	10193-103E4	42.72	0.72	3.36	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	239.03	6.66	8.04	11.02	2.98
ductal cell carcinoma cell line:KLM-1	10438-106E6	216.18	0.77	19.23	1.28	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	148.53	0.48	19.50	1.93	0.96
ductus deferens, adult	10196-103E7	60.80	1.00	2.49	0.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	89.29	0.00	0.00	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	105.20	7.36	3.68	4.41	0.74
dura mater, adult, donor1	10041-101F5	121.65	0.25	2.73	0.74	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	164.11	0.67	28.20	1.11	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	164.36	1.00	26.22	1.00	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	55.50	1.23	3.08	1.23	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	78.10	1.51	2.72	0.91	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	81.82	0.31	4.94	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	77.49	1.31	5.25	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	237.32	0.67	6.37	1.34	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	176.16	1.99	5.26	3.81	1.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	121.90	2.57	5.79	3.38	0.80
epidermoid carcinoma cell line:A431	10426-106D3	191.75	0.89	12.89	0.89	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	119.22	0.11	6.93	0.55	0.22
epididymis, adult	10197-103E8	62.37	1.47	2.09	0.63	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	107.16	1.24	9.05	2.48	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	88.48	1.97	5.90	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	276.91	5.11	13.37	3.01	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	285.61	2.76	11.42	2.26	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	254.53	2.80	14.56	3.14	1.34
esophagus, adult, pool1	10015-101C6	116.58	0.53	2.34	0.85	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	408.52	1.25	7.14	1.88	0.63
eye - muscle inferior rectus, donor1	10272-104E2	38.63	0.00	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	29.46	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	35.72	1.49	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	45.86	0.00	2.29	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	40.81	1.46	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	80.34	0.51	3.05	1.02	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	149.00	3.46	9.10	1.67	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	155.98	2.85	20.42	4.04	0.95
frontal lobe, adult, pool1	10040-101F4	86.32	0.56	8.82	0.47	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	102.08	1.50	3.30	2.40	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	148.04	0.46	8.14	0.18	0.09
gall bladder, adult	10198-103E9	49.25	0.00	2.66	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	148.71	0.54	1.07	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	96.73	0.37	2.24	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	65.05	1.90	2.11	2.53	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	176.40	3.29	3.87	4.45	1.55
gastric cancer cell line:AZ521	10549-107H9	292.33	1.31	19.35	0.98	0.82
gastric cancer cell line:GSS	10560-108A2	155.59	2.75	11.90	5.49	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	126.79	1.60	4.57	2.74	0.69
giant cell carcinoma cell line:LU65	10487-107B1	391.49	2.41	19.96	4.13	2.52
giant cell carcinoma cell line:Lu99B	10433-106E1	193.56	0.56	19.17	0.70	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	80.56	1.00	4.49	2.74	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	98.27	1.06	6.86	1.58	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	107.01	0.70	5.20	0.98	0.70
glioblastoma cell line:T98G	10485-107A8	136.53	1.21	6.73	0.55	0.77
glioma cell line:GI-1	10413-106B8	152.59	0.88	4.39	0.29	0.59
globus pallidus - adult, donor10196	10175-103C4	38.63	0.73	5.10	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	85.19	0.73	3.42	1.22	0.00
globus pallidus, adult, donor10258	10367-105F7	41.08	0.00	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	45.30	0.53	2.66	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	107.67	0.00	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	94.08	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	46.40	0.64	2.56	0.64	0.96
hIPS +CCl2, biol_rep1	14383-156B9	173.55	0.92	16.07	0.92	0.92
hIPS +CCl2, biol_rep2	14384-156C1	154.55	2.74	22.86	2.29	0.91
hIPS +CCl2, biol_rep3	14385-156C2	148.14	3.22	17.39	3.22	0.64
hIPS, biol_rep1	14380-156B6	185.41	0.00	25.87	5.75	0.00
hIPS, biol_rep2	14381-156B7	128.26	2.74	21.26	6.17	1.37
hIPS, biol_rep3	14382-156B8	72.83	1.10	9.93	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	131.89	6.32	11.49	3.74	1.15
heart - mitral valve, adult	10205-103F7	59.79	0.60	1.79	0.30	1.20
heart - pulmonic valve, adult	10206-103F8	73.21	1.31	2.35	1.83	0.00
heart - tricuspid valve, adult	10207-103F9	110.74	2.50	2.50	1.67	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	48.16	0.20	1.63	0.20	0.61
heart, adult, diseased, donor1	10051-101G6	33.21	1.28	0.85	1.70	0.43
heart, adult, pool1	10016-101C7	57.26	0.69	1.15	0.23	0.00
heart, fetal, pool1	10046-101G1	113.67	0.41	3.70	0.31	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	53.37	0.31	3.70	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	137.94	0.00	9.51	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	399.55	3.31	18.45	3.76	1.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	465.95	5.58	21.36	6.19	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	482.12	3.13	23.65	4.55	2.02
hepatoma cell line:Li-7	10484-107A7	164.04	1.33	4.56	1.56	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	180.60	2.01	11.96	1.41	0.90
hippocampus - adult, donor10196	10169-103B7	57.73	0.95	3.79	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	74.90	1.84	4.29	1.02	0.41
hippocampus, adult, donor10258	10374-105G5	38.84	3.49	5.98	4.48	0.50
hippocampus, newborn, donor10223	10363-105F3	42.30	0.70	5.99	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	305.17	1.83	24.41	4.88	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	144.52	1.96	13.16	2.36	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	156.40	1.27	21.58	2.79	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	55.82	0.00	9.59	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	69.46	2.84	5.42	6.71	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	79.34	0.76	8.35	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	85.83	1.46	5.26	1.46	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	109.44	1.29	8.62	3.66	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	92.17	0.00	5.42	1.25	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	125.97	0.24	9.00	1.66	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	112.66	3.05	5.79	1.29	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	130.62	1.35	4.04	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	163.21	1.72	12.52	5.63	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	146.90	5.90	11.30	15.23	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	303.72	1.75	22.69	3.49	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	73.12	1.15	6.68	1.15	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	71.52	1.31	3.92	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	84.46	0.50	6.50	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	88.17	1.88	7.54	2.83	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	100.49	1.36	10.46	1.36	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	84.57	0.63	4.70	2.82	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	70.71	0.82	3.27	1.14	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	81.00	1.74	4.94	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	63.97	0.90	2.69	1.20	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	146.69	2.96	15.15	7.39	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	148.63	2.00	15.69	2.28	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	203.75	2.04	15.11	2.04	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	72.53	2.11	5.28	4.22	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	62.71	0.63	6.65	1.58	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	65.06	0.61	6.36	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	88.95	0.52	2.07	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	81.03	1.99	6.64	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	71.57	1.28	5.13	1.03	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	97.91	0.51	4.35	1.79	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	75.72	2.27	6.82	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	72.59	1.34	4.37	2.02	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	150.22	1.69	15.70	2.42	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	179.15	1.34	11.14	3.12	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	156.59	1.95	13.66	1.95	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	86.80	1.83	7.03	0.92	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	819.82	6.51	52.05	19.52	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	121.46	1.32	9.27	0.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	102.89	0.55	8.76	1.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	82.15	2.17	7.60	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	79.00	2.14	6.76	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	50.12	0.00	4.77	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	129.87	1.08	9.07	0.95	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	63.04	0.81	4.04	0.81	0.27
immature langerhans cells, donor1	11904-125F5	153.28	0.48	5.09	0.24	0.00
immature langerhans cells, donor2	11905-125F6	72.88	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	79.78	0.28	7.85	0.38	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	73.48	1.30	1.95	1.95	0.00
kidney, adult, pool1	10017-101C8	81.60	0.70	3.10	0.60	0.30
kidney, fetal, pool1	10045-101F9	79.29	0.21	2.76	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	260.32	0.28	11.36	0.57	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	163.40	1.38	4.15	2.21	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	64.04	0.55	2.20	0.37	0.00
left atrium, adult, donor1	10079-102A7	50.13	2.18	2.18	1.09	0.00
left ventricle, adult, donor1	10078-102A6	42.98	1.52	1.01	1.01	1.52
leiomyoblastoma cell line:G-402	10721-110A1	158.15	1.64	13.13	1.09	0.55
leiomyoma cell line:10964C	10569-108B2	51.37	1.08	5.03	1.08	0.00
leiomyoma cell line:15242A	10570-108B3	46.20	0.00	4.35	1.63	0.54
leiomyoma cell line:15425	10571-108B4	80.13	1.21	6.56	4.37	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	0.00	19.05	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	42.87	2.09	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	284.64	4.37	13.93	3.07	1.18
liposarcoma cell line:KMLS-1	10782-110G8	53.74	0.62	2.34	0.31	0.47
liposarcoma cell line:SW 872	10726-110A6	109.66	0.85	3.29	0.61	0.49
liver, adult, pool1	10018-101C9	83.79	0.97	1.62	0.49	0.32
liver, fetal, pool1	10086-102B5	22.58	0.00	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	46.23	1.02	7.00	0.58	0.00
locus coeruleus, adult, donor10252	10165-103B3	65.70	2.40	4.80	0.55	0.18
locus coeruleus, adult, donor10258	10375-105G6	31.60	1.41	5.92	1.69	0.28
locus coeruleus, newborn, donor10223	10362-105F2	104.73	0.00	8.41	1.68	0.00
lung adenocarcinoma cell line:A549	10499-107C4	185.31	0.69	4.84	0.28	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	144.09	0.69	6.20	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	101.76	0.79	3.16	1.58	0.53
lung, adult, pool1	10019-101D1	87.30	0.47	2.13	0.35	0.24
lung, fetal, donor1	10068-101I5	99.32	0.86	5.42	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	46.28	1.83	1.83	1.83	0.92
lymph node, adult, donor1	10077-102A5	101.77	1.42	3.31	2.84	0.95
lymphangiectasia cell line:DS-1	10727-110A7	180.16	1.97	6.36	2.63	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	314.38	2.11	17.66	1.21	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	195.38	0.85	9.34	0.00	0.00
mature adipocyte, donor1	12231-129F8	103.45	0.00	2.66	0.89	0.00
mature adipocyte, donor2	12232-129F9	126.59	0.62	4.36	0.00	0.00
mature adipocyte, donor3	12233-129G1	119.95	0.00	4.50	0.24	0.00
mature adipocyte, donor4	12234-129G2	161.62	0.00	4.47	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	378.59	1.91	18.11	1.43	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	63.17	1.13	3.38	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	69.70	1.66	5.52	0.92	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	38.44	0.95	5.40	0.64	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	117.71	1.28	11.09	1.71	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	62.10	1.35	6.08	6.58	2.36
medial temporal gyrus, adult, donor10252	10156-103A3	73.22	2.55	4.88	0.85	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	0.00	13.48	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	803.80	57.41	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	53.48	0.72	7.54	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	44.13	0.65	1.95	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	76.47	1.08	4.33	0.31	0.31
medulla oblongata, adult, pool1	10038-101F2	60.08	0.33	4.41	0.33	0.08
medulla oblongata, newborn, donor10223	10361-105F1	49.30	1.04	3.82	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	533.82	7.09	26.13	9.74	2.88
medulloblastoma cell line:ONS-76	10759-110E3	110.78	1.59	11.98	1.22	0.24
melanoma cell line:COLO 679	10514-107E1	156.83	0.72	5.89	0.29	0.14
melanoma cell line:G-361	10465-106H6	188.94	1.63	10.04	1.90	0.54
meningioma cell line:HKBMM	10691-109F7	92.98	1.81	4.52	2.35	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	125.12	1.76	7.05	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	141.80	0.00	11.67	1.04	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	113.54	1.38	7.83	0.61	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	89.80	1.45	4.54	0.73	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	78.27	1.24	5.38	1.24	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	62.65	0.28	1.40	0.70	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	57.19	0.39	2.12	1.16	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	62.47	0.69	1.39	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	81.18	0.34	4.12	1.03	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	70.27	0.35	2.88	1.50	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	64.20	1.06	4.77	0.66	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	64.68	0.54	5.13	1.22	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	64.30	1.14	3.41	0.71	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	63.89	0.66	3.29	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	60.05	0.55	2.63	0.55	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	64.93	0.35	4.19	2.79	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	44.92	0.82	2.04	0.82	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	34.87	0.72	3.59	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	39.72	0.31	1.03	0.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	39.21	0.00	1.14	0.68	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	146.85	0.00	13.43	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	45.43	0.45	2.09	0.30	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	48.58	0.35	1.49	0.61	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	61.11	1.84	1.84	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	44.64	0.57	3.15	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	64.84	1.68	6.74	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	40.64	0.91	1.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	67.53	0.77	3.07	1.53	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	60.73	1.05	3.14	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	51.45	1.23	1.85	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	71.31	0.24	3.06	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	66.00	0.34	2.03	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	54.62	1.57	3.93	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	53.29	0.46	2.32	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	85.95	0.58	3.17	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	62.69	0.67	3.12	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	56.00	0.48	3.85	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	64.53	0.73	2.93	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	53.03	1.01	2.69	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	49.53	0.00	1.64	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	55.84	0.43	3.44	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	49.22	0.00	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	72.31	0.00	5.16	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	52.62	1.62	4.55	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	42.19	0.00	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	54.91	0.53	3.20	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	42.52	0.00	3.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	48.59	2.33	2.72	1.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	50.37	0.00	6.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	56.63	0.00	2.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	59.89	1.19	5.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	41.43	0.00	2.44	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	50.04	1.27	3.80	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	58.63	0.00	3.45	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	45.13	4.30	4.30	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	63.87	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	61.99	3.44	0.00	3.44	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	63.16	1.63	1.63	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	75.47	0.79	0.79	2.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	76.05	1.77	1.77	6.48	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	74.19	0.31	3.12	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	74.85	6.68	2.67	5.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	109.99	2.37	2.37	8.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	102.72	2.57	2.57	7.70	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	109.46	0.69	6.20	4.82	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	96.49	1.98	2.97	3.46	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	85.23	2.24	3.36	5.61	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	87.78	0.64	3.82	5.72	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	71.33	0.40	3.63	2.42	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	80.68	0.00	2.18	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	44.35	0.00	2.53	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	86.78	0.00	1.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	90.38	0.00	4.52	13.56	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	72.48	2.47	0.82	2.47	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	62.31	0.20	2.18	0.20	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	61.65	0.97	2.27	3.24	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	74.36	1.02	3.06	4.07	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	47.20	0.00	2.32	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	219.00	0.47	6.14	2.13	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	131.82	0.23	3.71	0.70	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	89.75	0.00	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	80.66	4.21	4.21	1.75	0.21
mesothelioma cell line:Mero-25	10850-111F4	300.49	5.67	22.92	5.67	0.91
mesothelioma cell line:Mero-41	10851-111F5	181.40	1.96	9.29	2.20	0.98
mesothelioma cell line:Mero-48a	10852-111F6	77.94	1.77	4.65	2.21	0.66
mesothelioma cell line:Mero-82	10853-111F7	160.31	6.83	5.52	8.15	1.84
mesothelioma cell line:Mero-83	10854-111F8	88.51	3.57	4.43	2.04	0.17
mesothelioma cell line:Mero-84	10855-111F9	95.30	1.26	5.31	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	103.52	1.66	6.42	1.04	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	112.14	1.49	6.79	2.65	0.33
mesothelioma cell line:NCI-H226	10846-111E9	138.10	1.45	9.41	2.35	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	116.16	1.02	5.81	1.02	0.34
mesothelioma cell line:NCI-H28	10845-111E8	163.37	1.53	11.71	3.82	1.53
mesothelioma cell line:No36	10857-111G2	137.98	2.61	9.46	2.28	0.98
mesothelioma cell line:ONE58	10858-111G3	88.06	1.35	3.79	0.54	0.81
migratory langerhans cells, donor1	11901-125F2	113.04	0.38	3.84	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	69.48	0.61	2.81	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	134.97	0.18	4.13	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	69.21	0.65	2.61	3.59	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	69.73	1.27	1.70	0.85	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	108.50	0.69	5.53	1.38	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	123.69	1.52	5.90	1.14	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	368.85	2.22	7.02	1.66	0.00
myeloma cell line:PCM6	10474-106I6	166.63	1.38	2.37	0.59	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	70.51	2.54	1.52	1.52	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	68.26	0.59	2.75	1.18	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	145.19	0.33	12.26	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	167.08	0.51	14.78	0.44	0.07
nasal epithelial cells, donor2	12227-129F4	137.45	0.55	7.18	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	511.43	1.38	9.66	0.69	0.23
neuroblastoma cell line:NB-1	10539-107G8	206.54	1.12	14.78	0.94	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	152.89	4.22	6.12	4.64	1.05
neuroblastoma cell line:NH-12	10555-107I6	372.89	5.78	7.83	8.01	3.54
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	192.39	6.17	5.69	4.03	1.42
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	153.15	2.85	4.91	2.85	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	174.49	3.22	6.24	1.61	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	126.52	1.27	8.90	1.91	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	64.41	1.06	2.13	0.27	0.27
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	264.17	1.52	7.95	1.01	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	64.04	0.00	9.61	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	37.83	2.56	2.24	0.96	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	43.36	0.79	3.15	1.84	0.26
nucleus accumbens, adult, pool1	10037-101F1	77.52	0.09	7.69	0.19	0.09
occipital cortex - adult, donor10196	10172-103C1	51.51	4.12	4.12	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	69.51	1.34	5.10	1.07	0.00
occipital cortex, newborn, donor10223	10355-105E4	42.95	0.36	6.91	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	45.66	1.31	5.77	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	102.13	2.57	8.15	0.00	0.00
occipital pole, adult, pool1	10036-101E9	38.40	0.08	4.42	0.24	0.08
olfactory region, adult	10195-103E6	51.39	2.29	5.35	1.53	0.38
optic nerve, donor1	10277-104E7	30.02	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	209.70	0.57	7.97	1.25	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	220.37	0.69	16.49	0.14	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	86.36	2.03	3.39	3.73	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	77.51	1.62	3.35	1.73	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	33.22	0.00	2.06	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	227.98	0.93	4.67	3.74	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	145.47	0.64	5.94	1.48	0.00
ovary, adult, pool1	10020-101D2	249.74	0.79	3.23	1.22	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	67.10	0.18	4.58	0.92	1.10
pancreas, adult, donor1	10049-101G4	132.63	1.88	2.82	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	128.03	0.56	1.68	3.07	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	114.65	4.26	5.28	3.58	2.04
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	154.65	0.33	3.64	0.66	0.33
paracentral gyrus, adult, pool1	10035-101E8	67.91	0.55	7.41	0.27	0.00
parietal cortex, adult, donor10258	10373-105G4	44.04	2.20	2.94	2.94	0.73
parietal lobe - adult, donor10196	10171-103B9	47.02	0.94	8.46	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	58.72	2.28	4.85	1.43	0.00
parietal lobe, adult, pool1	10034-101E7	63.36	0.70	7.40	0.35	0.09
parietal lobe, fetal, donor1	10072-101I9	93.10	1.94	6.79	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	54.58	1.12	6.36	0.75	0.00
parotid gland, adult	10199-103F1	101.75	0.00	2.47	0.62	0.00
penis, adult	10200-103F2	71.44	0.54	3.22	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	417.61	9.30	21.94	8.18	2.97
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	93.97	2.62	4.52	1.60	1.02
pineal gland - adult, donor10196	10179-103C8	77.40	1.29	9.03	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	129.10	1.18	7.11	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	55.81	0.63	9.41	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	117.37	0.00	5.06	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	184.50	1.04	7.82	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	55.33	0.00	3.40	2.55	0.00
placenta, adult, pool1	10021-101D3	91.38	0.75	2.37	0.54	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	210.29	1.85	13.77	2.25	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	79.22	0.47	3.11	0.31	0.16
pons, adult, pool1	10033-101E6	68.85	0.26	7.75	0.60	0.09
postcentral gyrus, adult, pool1	10032-101E5	57.27	0.61	6.19	0.61	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	31.37	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	101.38	1.46	7.57	1.75	0.58
prostate cancer cell line:PC-3	10439-106E7	161.54	1.82	7.08	1.63	0.73
prostate, adult, pool1	10022-101D4	139.48	0.63	2.18	0.82	0.45
putamen, adult, donor10196	10176-103C5	84.98	0.94	5.67	0.24	0.47
putamen, adult, donor10252	10152-102I8	64.70	1.96	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	75.40	3.28	10.93	3.28	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	59.68	3.38	3.62	2.66	0.72
putamen, newborn, donor10223	10365-105F5	137.94	0.00	11.24	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	383.45	1.16	4.95	1.75	0.58
rectum, fetal, donor1	10067-101I4	129.36	1.39	5.56	4.17	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	115.12	0.85	9.33	1.27	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	174.80	1.66	7.87	1.66	4.56
retina, adult, pool1	10030-101E3	85.98	0.30	1.79	0.20	0.00
retinoblastoma cell line:Y79	10475-106I7	440.88	2.86	25.20	3.64	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	134.38	1.72	9.59	1.23	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	359.09	1.69	11.81	1.97	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	27.28	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	143.73	3.08	6.80	1.13	0.81
salivary acinar cells, donor2	11772-123I8	144.85	3.30	4.27	3.30	0.41
salivary acinar cells, donor3	11773-123I9	51.64	1.99	0.66	1.99	0.00
salivary gland, adult, pool1	10093-102C3	63.49	0.57	2.86	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	159.18	0.59	9.02	1.35	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	162.46	1.65	7.64	1.18	0.82
seminal vesicle, adult	10201-103F3	58.73	4.23	2.12	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	77.74	0.73	1.94	1.21	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	54.10	1.26	2.52	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	61.22	1.00	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	103.96	1.34	4.57	1.88	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	150.10	0.44	8.95	0.66	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	274.57	0.77	7.35	0.90	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	127.68	3.55	13.48	3.55	0.00
skeletal muscle, adult, pool1	10023-101D5	283.77	1.68	10.07	1.92	0.72
skeletal muscle, fetal, donor1	10066-101I3	97.49	4.02	0.00	2.01	2.01
skin, adult, donor1	10074-102A2	108.56	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	119.93	3.79	3.16	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	80.71	1.33	7.34	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	94.56	1.89	5.36	2.52	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	211.83	2.70	17.93	2.89	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	407.12	1.15	22.58	1.48	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	396.33	5.15	40.69	4.50	2.25
small cell lung carcinoma cell line:WA-hT	10562-108A4	114.41	0.87	5.67	1.96	0.00
small intestine, adult, pool1	10024-101D6	130.43	1.07	2.99	0.72	0.00
small intestine, fetal, donor1	10064-101I1	130.22	2.46	2.46	2.70	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	70.27	1.54	4.10	2.05	1.03
smooth muscle, adult, pool1	10048-101G3	98.99	0.78	2.33	1.03	1.03
somatostatinoma cell line:QGP-1	10781-110G7	87.11	1.34	2.95	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	64.00	1.38	3.44	0.69	0.23
spinal cord, adult, donor10252	10159-103A6	100.93	0.39	2.76	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	72.64	0.00	2.77	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	47.57	2.44	1.83	1.83	0.61
spinal cord, newborn, donor10223	10359-105E8	82.66	0.46	6.89	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	50.63	0.90	3.29	0.60	0.30
spleen, adult, pool1	10025-101D7	109.47	0.66	1.43	0.11	0.11
spleen, fetal, pool1	10044-101F8	67.70	0.24	2.07	0.24	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	208.37	1.66	13.77	1.55	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	215.13	1.52	6.65	0.76	1.14
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	62.20	1.75	4.54	2.45	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	225.18	1.56	15.64	3.91	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	375.95	1.91	18.91	2.48	1.80
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	107.59	1.69	6.78	2.12	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	90.96	0.85	2.12	0.42	0.00
stomach, fetal, donor1	10062-101H8	65.15	0.00	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	101.40	3.42	1.14	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	78.93	0.62	3.95	0.62	0.21
substantia nigra, adult, donor10258	10371-105G2	55.86	2.59	5.17	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	51.58	1.41	4.95	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	325.79	4.59	23.61	6.19	3.21
temporal lobe, adult, pool1	10031-101E4	39.42	0.08	4.32	0.51	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	72.65	1.42	6.41	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	70.77	2.20	4.40	1.32	0.44
tenocyte, donor1	11763-123H8	65.63	2.79	0.70	1.40	1.75
tenocyte, donor2	11765-123I1	47.31	1.91	2.29	3.05	0.38
tenocyte, donor3	11768-123I4	47.07	1.48	4.82	3.34	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	203.95	1.87	23.45	2.89	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	102.20	0.92	4.78	1.85	0.62
teratocarcinoma cell line:PA-1	10807-111A6	142.27	3.25	12.09	0.93	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	159.95	2.29	13.46	2.29	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	331.66	2.27	23.45	4.54	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	250.08	1.96	9.49	2.07	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	202.26	3.26	12.38	14.01	4.23
testis, adult, pool1	10026-101D8	139.91	0.86	10.74	0.75	0.11
testis, adult, pool2	10096-102C6	106.00	6.32	14.43	4.96	2.26
thalamus - adult, donor10196	10168-103B6	64.03	1.10	3.31	1.10	0.00
thalamus, adult, donor10252	10154-103A1	74.39	0.94	4.53	0.78	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	44.65	0.00	15.40	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	26.84	2.47	3.95	0.99	0.33
thalamus, newborn, donor10223	10366-105F6	67.89	1.15	7.48	0.58	0.00
throat, adult	10209-103G2	72.90	1.00	1.50	0.25	0.00
throat, fetal, donor1	10061-101H7	93.85	3.66	3.05	1.22	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	240.86	3.18	12.32	1.99	1.19
thymus, adult, pool1	10027-101D9	118.30	0.50	5.57	0.60	0.10
thymus, fetal, pool1	10043-101F7	103.28	0.42	4.78	0.52	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	67.81	0.53	3.72	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	154.08	2.65	8.66	2.37	1.96
thyroid, adult, pool1	10028-101E1	140.62	0.65	3.55	0.47	0.09
thyroid, fetal, donor1	10060-101H6	51.68	2.37	3.16	2.37	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	58.51	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	76.75	1.63	3.49	2.09	0.47
tongue, fetal, donor1	10059-101H5	100.10	0.79	2.76	0.79	1.58
tonsil, adult, pool1	10047-101G2	128.53	0.60	3.61	0.40	0.00
trachea, adult, pool1	10029-101E2	138.48	0.57	3.44	0.41	0.25
trachea, fetal, donor1	10058-101H4	86.56	3.85	1.92	3.46	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	82.19	1.42	6.73	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	120.97	0.41	5.98	0.00	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	190.53	1.25	8.15	3.29	1.72
tridermal teratoma cell line:HGRT	10694-109G1	26.64	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	117.75	1.52	3.56	0.68	0.68
umbilical cord, fetal, donor1	10057-101H3	64.68	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	81.73	1.02	3.75	0.51	0.00
uterus, fetal, donor1	10055-101H1	104.43	2.05	2.05	2.05	0.00
vagina, adult	10204-103F6	67.20	0.65	1.94	1.29	0.00
vein, adult	10191-103E2	72.12	0.66	2.85	1.53	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	140.73	3.74	7.21	2.94	0.80